0MR5.LSE CellaVision AB

Healthcare Commercial Services & Supplies London Exchange
- SEK
Market cap
-
P/E
-
P/B
-
ROE
-
Dividend yield
1.27%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2022.

Is 0MR5.LSE undervalued?

Graham number

The Graham number of CellaVision AB cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

CellaVision AB fundamental analysis

No fundamental analysis for CellaVision AB yet.

CellaVision AB stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About CellaVision AB

CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides analyzers for microscopy systems; and DIFF-Line, a hematology lab that handles a smaller amount daily blood samples, as well as consists of three instruments, such as CellaVision DC-1, RAL SmearBox, and RAL StainBox for smearing, staining, and analyzing peripheral blood smears. It also provides CellaVision DC-1 fo…

Full company profile